High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.9M
$9,894,759
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Khattar Jack A.
• CEO
10b5-1 Sell
2026-03-13
$1,763,124Largex3
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2026-03-13 | $1,763,124Largex3 | S | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Khattar Jack A.
• CEO
10b5-1 Sell
2025-10-09
$3,029,336Largex2
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-09 | $3,029,336Largex2 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $91,506 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-01 | $1,931,116Large | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-30 | $414,371 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-29 | $491,485 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-23 | $1,393,899Large | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-22 | $779,921 | S | Form 4 |